Is Sumitomo Chemical India a Good Buy After Its Q1 FY27 Results?

Sumitomo Chemical India reported its financial results for the first quarter of fiscal year 2027, providing an early look at its performance. The company’s performance is closely tied to the broader chemical sector and its specific business segments, including agrochemicals, pharmaceuticals, and specialty chemicals. Investors often use these interim results to gauge the company's operational health and market positioning ahead of the full-year announcement.
For investors, these results are important because they offer a snapshot of the company's ability to generate revenue and manage costs during the ongoing fiscal year. Positive trends in key business areas can signal growth potential, while challenges may raise questions about future profitability. The stock's reaction will depend on how the results compare to market expectations and the company's strategic outlook.
Excerpt from Univest
Sumitomo Chemical India share price around Rs 500. 19.1% below 52-week high of Rs 617. Q1 FY27 revenue Rs 1,111 crore, up 1.4% YoY. PAT Rs 215 crore, up 20.4%. PE 43x. Updated: 4 Sept 2026 • 1:52 pm Sumitomo Chemical India's Q1 FY27 results were strong, with revenue at Rs 1,111 crore and PAT climbing 20% to Rs 215…Read the original at Univest
Key takeaways
- Category: Results.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.


